|
Clin Res Cardiol 100, Suppl 1, April 2011 |
||
|
P1349 - Coronary Calcifications as detected by Dual-Source Computed Tomography are not a Marker of Cardiac Allograft Vasculopathy in Patients after Heart Transplantation |
||
|
F. von Ziegler1, A. Knez2, M. Greif1, J. Rümmler1, B. Reichart3, I. Kaczmarek3, C. Becker4, G. Steinbeck1, A. Becker1 |
||
|
1Medizinische Klinik und Poliklinik I, Klinikum der Universität München, Campus Großhadern, München; 2Innere Medizin, Krankenhaus Weilheim, Weilheim; 3Herzchirurgische Klinik und Poliklinik, Klinikum der Universität München, Campus Großhadern, München; 4Institut für Klinische Radiologie, Klinikum der Universität München, Campus Großhadern, München; |
||
|
Background: Despite major improvements in immunosuppressive therapy regimes over the last decade, cardiac allograft vasculopathy (CAV) still remains a leading cause of morbidity and mortality after heart transplantation (HTX). High negative predictive values of cardiac computed tomography calcium scoring (CS) suggest a potential strength of this non-invasive modality in ruling out coronary heart disease (CHD) based on traditional coronary atherosclerosis. According to initial studies, CS also seems to be a non-invasive marker of CAV, and thus an auspicious diagnostic tool for clinical care of heart transplant recipients. This study sought to evaluate the clinical feasibility of dual-source computed tomography calcium scoring (DSCTCS) for the detection of CAV in particular as follow-up examination after HTX. Methods: An overall of 176 patients (139 male; 37 female; mean age: 50.0±12.4 years; range:19-75 years) underwent DSCTCS (Definition, Siemens Medical Solutions, Results: In 106 patients (60.2%; 87 male; 19 female; mean age: 51.1±12.7 years; range: 22-71 years) 78.2±51.6 months after heart transplantation procedure, coronary calcium deposits were detected. Mean overall coronary calcium volume score was calculated as 24.0±50.3 (range: 0-385). In 70 patients (39.8%; 52 male; 18 female; mean age: 48.3±11.8 years; range: 19-75 years, 66.0±48.1 months after heart transplantation) coronary calcium could be excluded. According to the results of Conclusion: According to our results, DSCTCS is not a valuable non-invasive diagnostic test for the detection of CAV after HTX. Diagnostic performance evaluation revealed insufficiency to recommend this modality. We hypothesize that coronary calcifications represent pre-existing or independently developing de-novo traditional coronary atherosclerosis rather than CAV. |
||
|
Clin Res Cardiol 100, Suppl 1, April 2011 Zitierung mit Vortrags- oder Posternummer s.o. DOI 10.1007/s00392-011-1100-y |
||
http://www.abstractserver.de/dgk2011/ft/abstracts/P1349.htm |